PRINCETON, N.J., Dec. 02, 2025 (GLOBE NEWSWIRE) -- Sonnet BioTherapeutics Holdings, Inc., (NASDAQ: SONN) (“Sonnet” or the “Company”) today announced that its stockholders approved, among other things, the proposed business combination with Hyperliquid Strategies Inc (“HSI”) and Rorschach I LLC at its special meeting of stockholders. The final voting results for the special meeting will be filed in a Form 8-K with the U.S. Securities and Exchange Commission. About Sonnet BioTherapeutics Holdings, Inc. Sonnet ...

Monthly release covers the period from November 1-30, 2025GIG HARBOR, Wash., Dec. 02, 2025 (GLOBE NEWSWIRE) -- IP Strategy (Nasdaq: IPST) (the “Company”), the first company to adopt a treasury reserve policy centered on the $IP token, releases its monthly publication detailing its validator business performance and broader ecosystem developments for tokenized intellectual property and AI-native data networks. The report is part of the Company’s ongoing monthly publication cycle designed to give the investm ...

MCLEAN, Va., Dec. 02, 2025 (GLOBE NEWSWIRE) -- Cycurion, Inc. ("Cycurion" or the "Company") (NASDAQ: CYCU), a publicly traded leader in technology and staffing solutions for the public sector, is proud to announce that it has been officially awarded a position on the State of Florida’s Management Consulting Services State Term Contract, as outlined in RFP No. 25-80101500-RFP-V2, issued by the Florida Department of Management Services (DMS). This award positions Cycurion as an approved vendor eligible to pro ...

TEL AVIV, Israel, Dec. 02, 2025 (GLOBE NEWSWIRE) -- PainReform Ltd. (Nasdaq: PRFX) today announced, through its pharmaceutical division, the commencement of its development plan for OcuRing™-K, LayerBio’s patented, drop-less, intraoperatively administered sustained-release ocular therapy designed to deliver controlled, site-specific release of ketorolac following cataract surgery. Following the closing of PainReform’s majority investment in LayerBio and the integration of OcuRing-K into PainReform’s develop ...

Global assignment of this unique name enhances international clarity, strengthens regulatory positioning, and supports olastrocel’s advancement across large unmet-need global marketsPHOENIX, Dec. 02, 2025 (GLOBE NEWSWIRE) -- Creative Medical Technology Holdings, Inc. (NASDAQ: CELZ) (“Creative Medical” or the “Company”), a clinical-stage biotechnology company developing next-generation regenerative and immune cell therapies, today announced that the World Health Organization (WHO) has approved “olastrocel” a ...

The patent relates to methods of administering therapeutically effective amounts of isolated allogeneic mesenchymal stem cells (MSCs) to patients with aging-related frailty with inflammaging and also to treat patients with non-ischemic dilated cardiomyopathyNon-ischemic dilated cardiomyopathy is a progressive disorder with no current cure, often leading to heart transplantationNo approved treatments for aging-related frailty, a syndrome affecting older individuals that impairs human Healthspan, and is chara ...

THIS NEWS RELEASE IS INTENDED FOR DISTRIBUTION IN CANADA ONLY AND IS NOT INTENDED FOR DISTRIBUTION TO UNITED STATES NEWSWIRE SERVICES OR DISSEMINATION IN THE UNITED STATES. VANCOUVER, British Columbia, Dec. 02, 2025 (GLOBE NEWSWIRE) -- Doman Building Materials Group Ltd. (“Doman” or the “Company”) (TSX: DBM) announced today that it has closed its previously announced private placement offering of $170 million aggregate principal amount of 7.50% senior unsecured notes (the “Notes”) due September 17, 2029 (th ...

WASHINGTON, Dec. 02, 2025 (GLOBE NEWSWIRE) -- ASP Isotopes Inc. NASDAQ: ASPI ("ASP Isotopes” or the “Company”), an advanced materials company dedicated to the development of technology and processes for the production of isotopes for use in multiple industries, today announced that, effective January 19, 2026, Paul Mann, the founder and Executive Chairman of ASP Isotopes, will resume his role as the Company’s Chief Executive Officer and continue as Executive Chairman. On September 29, 2025, it was announced ...

Company’s Operational Excellence and Growing Brand Portfolio Continue to Drive Leadership in the Highly Competitive NY Metropolitan MarketBELVIDERE, NJ, Dec. 02, 2025 (GLOBE NEWSWIRE) -- Edible Garden AG Incorporated (“Edible Garden” or the “Company”) (Nasdaq: EDBL, EDBLW), a leading provider of controlled environment agriculture (CEA) solutions and sustainable, locally grown organic produce, today announced that it will participate in the 2025 New York Produce Show and Conference, taking place December 3, ...

A Media Snippet accompanying this announcement is available by clicking on this link. NEW YORK, Dec. 02, 2025 (GLOBE NEWSWIRE) -- BLACK PEARL, a leading cultural sustainability agency, today launched its newest campaign as part of the company's Culture@ storytelling series, in collaboration with Getty Images (NYSE: GETY), a preeminent global visual content creator and marketplace, and Canon U.S.A., Inc., a leader in digital imaging solutions. Featuring prominent cultural figures and award-winning actors, i ...